The company said revenues for Q4 2023 totaled $17.303 billion, net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share, and Adjusted EBITDA totaled $3.618 billion. Net income for Q4 2022 was $2.081 billion.

1. 01

   The company said revenues for Q4 2023 totaled $17.303 billion, net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share, and Adjusted EBITDA totaled $3.618 billion. Net income for Q4 2022 was $2.081 billion.

2. 02

   HCA Healthcare said revenues for 2023 totaled $64.968 billion, and net income attributable to HCA Healthcare, Inc. totaled $5.242 billion, or $18.97 per diluted share. It said net income for 2022 was $5.643 billion, and results for 2022 included gains on sales of facilities of $1.301 billion.

3. 03

   The company said its Board of Directors authorized an additional share repurchase program for up to $6 billion and declared a quarterly cash dividend of $0.66 per share. The dividend will be paid on March 29, 2024 to stockholders of record at the close of business on March 15, 2024.

4. 04

   HCA Healthcare said it expects revenues for 2024 of $67.75 to $70.25 billion and Adjusted EBITDA of $12.85 to $13.55 billion. It also said Michael A. Marks will serve as Executive Vice President and Chief Financial Officer effective May 1, 2024, following the retirement of William B. Rutherford.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.